MAPT and Alzheimer disease: On the other hand, many animal studies on the model of T2DM confirmed that T2DM promotes the development and accumulation of AD-associated pathologies, such as amyloid-β plaques, tau phosphorylation, and neurofibrillary lesions [73,74]